This website, owned by Alantra Partners S.A., uses cookies, including third-party cookies, to better understand how you use our website, offer better functionality and customization levels. For more information on how we use cookies, please see our Cookie Policy. Please, configure your cookie preferences or accept them all to continue navigating in our website.

Config Accept

Configure your cookies

Close ×

These are the cookies we use on our website. You can configure your preferences and choose how you want your data to be used for the following purposes.

Own / Mandatory / Technical

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences or filling in forms.

Analytical cookies:

These cookies collect information regarding the use of the web page, such as time spent on the page and content visited, to measure its performance and improve navigation.

Accept all Save preferences

About Us
What We Do
- Investment Banking
  - Overview
  - Technology
  - FIG
  - Healthcare
  - All Sectors
  - Services
  - Transactions
- Alternative Asset Management
Team
Careers
Shareholders & Investors
News & Insights
Global Presence
Contact Us

Corporate News

Consumer Health | 2H 2024 Market Review
Read More
Software Valuations and Insights Report | H2 2024
Read More

Catherine Halford

Date 4 October 2021

Back to News

PARA ACCEDER A ACCIONISTAS E INVERSORES PINCHE AQUI

Contact
Terms & Conditions
Data Protection
Cybersecurity
Cookies Decl
Config cookies
Whistleblowing

Configure your cookies

Corporate News

Consumer Health | 2H 2024 Market Review

Software Valuations and Insights Report | H2 2024

Catherine Halford